Valacyclovir HydrochlorideThird Party Manufacturing in India

Valacyclovir Hydrochloride works by acting as a prodrug that rapidly converts into acyclovir after oral administration. It inhibits viral DNA synthesis by phosphorylating into acyclovir triphosphate, which subsequently binds to and blocks viral DNA polymerase to help the body halt viral replication. Unlike direct topical antiviral formulations, it achieves significantly higher systemic bioavailability and plasma levels. It is highly effective and well-tolerated in reducing viral shedding and healing active lesions.

Therapeutic Uses

• Herpes Zoster: Indicated for the treatment of shingles to accelerate the healing of lesions and manage acute pain.
• Genital Herpes: Used to treat initial and recurrent episodes as well as suppressive therapy to reduce transmission risk.
• Herpes Labialis: Prescribed for the treatment of cold sores around the mouth to limit duration and severity.

Why Manufacturers Choose Valacyclovir Hydrochloride

Valacyclovir Hydrochloride third party manufacturing in India represents a highly profitable commercial avenue due to stable global demand for systemic antiviral therapeutics. Celesta Healthcare secures supply through partner facilities that maintain robust compliance standards, including WHO-GMP compliance, ensuring consistent chemical purity for CAS 124832-27-5. The market for this molecule is driven by a preference for prodrugs that offer superior patient adherence and dosing intervals compared to standard options. Our production facilities are WHO-GMP certified, providing formulation buyers with competitive scaling advantages and high-quality finished solid dosages.